Filtered By:
Vaccination: Influenza Vaccine

This page shows you your search results in order of date. This is page number 11.

Order by Relevance | Date

Total 427 results found since Jan 2013.

Shoulder Pain and Injury after COVID-19 Vaccination
Yale J Biol Med. 2022 Jun 30;95(2):217-220. eCollection 2022 Jun.ABSTRACTShoulder injury related to vaccine administration (SIRVA) is a term given to describe shoulder pain and dysfunction arising within 48 hours after vaccine administration and lasting for more than one week. While SIRVA is most commonly seen after influenza and tetanus vaccines, there have been a few recent case reports describing SIRVA-like symptoms after COVID-19 vaccine administration. Two patients presented to the shoulder surgeon's practice center with complaints of shoulder stiffness and pain following the COVID-19 vaccine. The first patient was a ...
Source: The Yale Journal of Biology and Medicine - July 5, 2022 Category: Universities & Medical Training Authors: Dipit Sahu Source Type: research

Who ’ s Afraid of Needles?
Discussion There are products that are valued highly because of their design and function are elegantly suited for their use. Books would be one example and the hypodermic needle is another. Medical hypodermic needles are used for accessing bodily spaces (e.g. vascular, peritoneal, subarachnoid, dermal, etc.), obtaining specimens (both solid tissue and liquid) and to deliver drugs, biologicals, fluids and other treatments to patients. Medical procedures involving some type of needle are the most common procedures taught to health care providers. A brief history of syringes and hypodermic needles can be found here. A variet...
Source: PediatricEducation.org - April 4, 2022 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

SIRVA (Shoulder Injury Related to Vaccine Administration) following mRNA COVID-19 Vaccination: Case discussion and literature review
We present a reported case of SIRVA following a mRNA COVID-19 vaccination and review the current literature. As we embark on a worldwide scale of COVID-19 vaccination, it is of utmost important that we use proper vaccination techniques and screen patients at risk of SIRVA. This would improve the efficacy of the vaccine and improve the outcomes of the vaccination programme.PMID:35339304 | DOI:10.1016/j.vaccine.2022.03.037
Source: Vaccine - March 27, 2022 Category: Allergy & Immunology Authors: Wen Loong Paul Yuen Sir Young James Loh Dehao Bryan Wang Source Type: research

Pharmacists time spent: Space for Pharmacy-based Interventions and Consultation TimE (SPICE)--an observational time and motion study
Conclusions This is the first study to quantify the pharmacists’ tasks in Australian community pharmacies. Much time is being spent on dispensing, supply and management activities with little time for providing additional professional services. An extra supporting pharmacist is likely necessary to increase professional services. These findings could support future research around barriers and enablers of conducive workflows and of extended professional services.
Source: BMJ Open - March 2, 2022 Category: General Medicine Authors: Karia, A., Norman, R., Robinson, S., Lehnbom, E., Laba, T.-L., Durakovic, I., Balane, C., Joshi, R., Webster, R. Tags: Open access, Health services research Source Type: research

Frozen Shoulder Related to Influenza Vaccine Administration
We present the case of a 46-year-old woman who presented clinically with frozen shoulder that was progressively worse and temporally related to her yearly influenza vaccination. The patient failed conservative management, and 7 months postvaccination, the patient underwent shoulder manipulation under anesthesia with good results. Vaccination-related shoulder dysfunction after high-deltoid intramuscular penetration and infiltration into the subdeltoid/subacromial bursa can cause a severe local inflammatory response that clinically may present as frozen shoulder. A case report and review of the literature on suspected frozen...
Source: Clinical Journal of Sport Medicine - March 1, 2022 Category: Sports Medicine Tags: Case Report Source Type: research

MAS-1, a novel water-in-oil adjuvant/delivery system, with reduced seasonal influenza vaccine hemagglutinin dose may enhance potency, durability and cross-reactivity of antibody responses in the elderly
CONCLUSION: MAS-1 adjuvant provided HA dose-sparing without safety concerns at the 0.3 mL dose, but the 0.5 mL dose caused late injection site reactions. MAS-1-adjuvanted IIV induced higher HAI antibody responses with prolonged durability including against historical strains, thereby providing greater potential vaccine efficacy in the elderly throughout an influenza season. Clinical Trial Registry: ClinicalTrials.gov # NCT02500680.PMID:35125224 | DOI:10.1016/j.vaccine.2022.01.035
Source: Vaccine - February 7, 2022 Category: Allergy & Immunology Authors: Geoffrey J Gorse Stephen Grimes Helen Buck Hussain Mulla Peter White Heather Hill Jeanine May Sharon E Frey Peter Blackburn Source Type: research